Applicator with capsules designed to deliver plasma energies for skin treatment
Patent Information
- Application Number
- FR2022006222
- Authority / Receiving Office
- FR · FR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-06-23
- Publication Date
- 2025-08-22
- Estimated Expiration
- 2042-06-23
Smart Images

Figure 00000009_0000 
Figure 00000009_0001 
Figure 00000010_0000
Abstract
Description
Title of the invention: Applicator with capsules designed to deliver plasma energies for skin treatment Summary
[0001] This summary is provided to present a selection of concepts in simplified form which are further described below in the Detailed Description. This summary is not intended to identify key features of the claimed subject matter or to be used as an aid in determining the scope of the claimed subject matter.
[0002] In one aspect, the present invention provides a skin care system comprising a dispensing device configured to deliver light therapy and plasma treatment, and an applicator configured to apply a formula comprising a reservoir configured to contain the formula, a roller ball configured to apply the formula, an attachment configured to attach the capsule to the dispensing device, and a microcontroller configured to control the dispensing device to apply the plasma treatment.
[0003] According to particular embodiments, this system comprises one or more of the following characteristics, taken in isolation or in all technically possible combinations: - the delivery device administers light therapy via one or more light sources; and - the one or more light sources are a ring of LEDs around a top of the dispensing device.
[0004] In another aspect, the invention provides a method of delivering multiple skin treatments using the skin care system, the method comprising selecting an applicator filled with a formula, placing the applicator in the dispensing device, identifying a plasma treatment to be applied based on the applicator, applying the formula, delivering light therapy, and delivering the plasma treatment. Description of the drawings
[0005] The foregoing aspects and numerous related advantages of this invention will be more readily appreciated as they become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, in which:
[0006] [Fig. 1] [Fig. 1] is an example of an applicator in accordance with this technology ;
[0007] [Fig.2] [Fig.2] is an example of a cross-section of an applicator in compliance with this technology;
[0008] [Fig.3] [Fig.3] is an example of a dispensing device in accordance with the present technology; and
[0009] [Fig.4] [Fig.4] is an example of a method of using a skin care system skin in accordance with this technology. Detailed description
[0010] Although illustrative embodiments have been illustrated and described, it will be appreciated that various changes may be made therein without departing from the spirit and scope of the invention.
[0011] The invention describes an applicator with a microcontroller that allows instructions to be sent to a delivery device to administer a plasma treatment while applying both a formula and light therapy. In some embodiments, the plasma treatment is a cold plasma treatment. In some embodiments, the plasma treatment is delivered using an electrode and one or more cables. In some embodiments, the delivery device applies a high voltage to the electrode using the one or more cables to generate a plasma when a roller ball on the applicator rolls over a surface.
[0012] [Fig. 1] is an example of an applicator in accordance with the present technology. The applicator 100 may include a rolling ball 110 and an attachment 120.
[0013] The roller ball 110 may be configured to dispense and apply a formula located in a reservoir within the applicator 100 (as shown in [Fig. 2]). In some embodiments, the roller ball 110 is made of plastic but in other embodiments, the roller ball 110 may be made of glass or metal.
[0014] In some embodiments, the applicator 100 also includes a fastener 120 configured to secure the applicator 100 in a dispensing device such as the dispensing device 200 in [Fig. 3]. While the fastener 120 is illustrated as a disc shaped to couple to the dispensing device, the fastener 120 may take any shape that allows the applicator to be secured to a dispensing device including a threaded fastener, a magnet, or a fastener configured to engage the dispensing device. In some embodiments, the fastener 120 is transparent so that the dispensing device is visible through the fastener.
[0015] In use, the applicator 100 may be placed within a dispensing device (as shown in [Fig. 3]) and secured to the dispensing device with the attachment 120. The roller ball 110 may be rolled over a surface, such as a user's skin, to apply a formula.
[0016] [Fig.2] is an example of a cross-section of an applicator 100 in accordance with the present technology. The applicator 100 may include a roller ball 110, an attachment 120, a reservoir 130 configured to hold a formula 140, a plunger 150, a microcontroller 160, and a processor 170. In some embodiments, the applicator further includes an electrode 180 and one or more cables 190a, 190b.
[0017] In some embodiments, the reservoir 130 is located within the applicator 100 and is configured to contain a formula 140. In some embodiments, the formula 140 is a skin care formula. In some embodiments, the skin care formula is a moisturizer, a toner, an acne treatment, a wrinkle treatment, a fine line treatment, or a cosmetic. As the ball 110 rolls, the formula 140 in the reservoir 130 is applied to a surface.
[0018] In some embodiments, the applicator 100 further includes a plunger 150 configured to push the formula 140 toward the ball 110 when the formula is applied. In some embodiments, the plunger 150 is directed by a circuit on a dispensing device or on the applicator itself to push the formula 140.
[0019] In some embodiments, the applicator 100 includes a microcontroller 160 configured to identify the formula type 140 within the applicator 100 relative to a dispensing device. In some embodiments, the microcontroller 160 further identifies the type of treatment that the applicator is to apply, namely the type of plasma treatment that is to be applied with the formula type 140. In some embodiments, the plasma treatment is a cold plasma treatment. In some embodiments, the plasma treatment is continuous. In some embodiments, the plasma treatment is pulsed. In some embodiments, the plasma treatment is applied over a specific period of time, for example, one minute or five minutes. In some embodiments, the applicator stops delivering the plasma treatment when the specific period of time has elapsed.The microcontroller 160 may also be used to identify anything regarding the formula 140 or the applicator 100, including the amount of formula 140 inside the applicator 100, the expiration date of the formula 140 inside the applicator 100, or when to replace the applicator 100.
[0020] In some embodiments, the applicator 100 further includes an electrode 180 and one or more cables 190A, 190B configured to deliver a plasma treatment. In some embodiments, the electrode 180 is the attachment 120. In some embodiments, the electrode 180 is made of a conductive material. In some embodiments, the electrode 180 is located within the attachment 120 (as shown in [Fig.l]) and is simply a member of the attachment 120. In some embodiments, one or more cables 190A, 190B connect to the electrode 180 to generate the plasma. In some embodiments, a high voltage is applied to the one or more cables 190A, 190B by the applicator. In some embodiments, a high voltage is applied to the one or more cables 190A, 190B from a delivery device (such as the delivery device 200 in [Fig.3]). In some embodiments, the high voltage is greater than 25 kV. In some embodiments, the high voltage is greater than 50 kV. In use, the high voltage may be applied to the one or more cables 190A, 190B and the electrode 180 to generate plasma while the user rolls the applicator 100 over their skin.
[0021] [Fig. 3] is an example of a dispensing device in accordance with the present technology. In some embodiments, the applicator 100 may be attached to a dispensing device 200. In some embodiments, the dispensing device includes an end 210, one or more light sources 220a, 220b, an actuator 230, and a contactless reader 240. In some embodiments, the applicator 100 connects to the dispensing device 200.
[0022] In some embodiments, the dispensing device 200 includes an end 210. The end 210 may be configured to be viewed through the attachment 120 on the applicator 100. In some embodiments, the end 210 includes one or more light sources 220a, 220b configured to deliver light therapy to a surface during application of the formula 140.
[0023] In some embodiments, the one or more light sources 220a, 220b are LEDs. In some embodiments, there are only two light sources 220a, 220b on the delivery device. In some embodiments, a first light source 220a is configured to deliver light therapy at a first wavelength. In some embodiments, a second light source 220b is configured to deliver light therapy at a second wavelength. In some embodiments, the light therapy at the first wavelength and the light therapy at the second wavelength are delivered simultaneously. In some embodiments, the light therapy and the application of the formula occur simultaneously. In some embodiments, there are one or more light sources 220a, 220b in a ring, located around the end 210 of the delivery device 200.
[0024] In some embodiments, the dispensing device 200 includes one or more actuators 230. Although the actuator 230 is illustrated as a button, in some embodiments, the actuator 230 may be a switch, a capacitive touch-type button, a dial, or the like. The actuator 230 may be designed to begin delivery of light therapy, to apply the formula, to control the plasma treatment, or all three. In some embodiments, the dispensing device 200 also includes a contactless chip reader 240 to read the microcontroller 160 on the applicator 100.
[0025] In use, a user may place an applicator 100 into the dispensing device 200. When the actuator 230 is actuated, the formula is applied, the light therapy is delivered, or both, simultaneously. A user may then apply the formula with the applicator 100. In addition, the plasma treatment may be delivered concurrently with the light therapy and the application of the formula.
[0026] [Fig. 4] is an example of a method 400 of using the skin care system in accordance with the present technology.
[0027] At block 410, an applicator is selected to have a specific formula and be configured to control the applicator and / or the delivery device to deliver a specific plasma treatment. In some embodiments, the plasma treatment is a cold plasma treatment. In some embodiments, the plasma treatment is continuous. In some embodiments, the plasma treatment is pulsed. In some embodiments, the plasma treatment is delivered over a specific amount of time, e.g., one minute or five minutes. In some embodiments, the applicator stops delivering the plasma treatment when the specific amount of time has elapsed. In some embodiments, the applicator further controls the applicator and / or the delivery device to deliver the plasma treatment at a specific voltage.
[0028] At block 420, the applicator is attached to the dispensing device. In some embodiments, the applicator is attached to the dispensing device with an attachment. In some embodiments, the applicator is transparent to allow one or more light sources on the dispensing device to emit light through the attachment. In some embodiments, the applicator slides, snaps, or connects into the dispensing device. In some embodiments, the applicator attaches to the dispensing device with a threaded fitting or a magnet.
[0029] At block 430, the dispensing device reads the microprocessor (or contactless chip) on the applicator with a contactless reader. In some embodiments, the microprocessor on the applicator identifies the type of formula, the type of plasma treatment to be administered, the life of the applicator, the amount of formula within the applicator, or a combination thereof.
[0030] In block 440, the formula is applied when the rolling ball is rolled along a surface. In some embodiments, the surface is a user's face. In some embodiments, the surface may be any portion of the skin of a user.
[0031] At block 450, light therapy is applied with the dispensing device. In some embodiments, the dispensing device includes an actuator configured to begin both the application of the formula and the delivery of the light therapy. In some embodiments, the dispensing device includes two or more light sources configured to deliver the light therapy. In some embodiments, the dispensing device is configured to provide two or more types of light therapy, one at a time or simultaneously. In these embodiments, one light source is configured to deliver a first light therapy and another light source is configured to deliver a second light therapy.In some embodiments, the first light therapy may comprise emitting a first light at a first wavelength and the second light therapy may comprise emitting a second light at a second wavelength.
[0032] At block 460, the plasma treatment is applied with the applicator. In some embodiments, blocks 440, 450, and 460 occur simultaneously.
[0033] At block 470, the method ends.
Claims
Claims
1. A skin care system comprising: a dispensing device (200) configured to deliver light therapy and plasma treatment; and an applicator (100) configured to apply a formula, the applicator (100) having a reservoir (130) configured to contain the formula (140), a roller ball (110) configured to apply the formula (140), an attachment configured to attach the capsule to the dispensing device (200), and a microcontroller (160) configured to control the dispensing device to apply the plasma treatment.
2. The skin care system of claim 1, wherein the light therapy and plasma treatment are administered simultaneously with the application of formula (140).
3. The skin care system of claim 1, wherein the delivery device (200) is configured to simultaneously apply two or more wavelengths of light therapy.
4. The skin care system of claim 1, wherein the delivery device (200) delivers light therapy via one or more light sources (220a, 220b).
5. The skin care system of claim 4, wherein the one or more light sources (220a, 220b) are a ring of LEDs around a top of the dispensing device (200).
6. The skin care system of claim 4, wherein the applicator (100) further comprises a transparent attachment such that light from the one or more light sources (220a, 220b) on the delivery device (200) can pass through the attachment to deliver light therapy.
7. The skin care system of claim 6, wherein the applicator (100) further comprises an electrode (180) configured to create a plasma in contact with a surface.
8. The skin care system of claim 7, wherein the attachment is the electrode (180).
9. The skin care system of claim 7, wherein the applicator (100) further comprises a cable connecting the electrode (180) to the dispensing device (200); and wherein the dispensing device distribution is further designed to pass a high voltage through the cable and into the electrode (180).